53. シェーグレン症候群 Sjogren syndrome Clinical trials / Disease details

臨床試験数 : 283 / 薬物数 : 320 - (DrugBank : 101) / 標的遺伝子数 : 56 - 標的パスウェイ数 : 181

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04597762 (ClinicalTrials.gov)	August 31, 2020	16/10/2020	Effect of Ciclosporin Eyedrops on Sjögren Syndrome	Effect of Ciclosporin Eyedrops on Ocular Symptoms and Optical Quality in Patients With Sjögren Syndrome	Dry Eye Syndromes	Drug: Cyclosporin;Drug: Hydrocortisone	Hospital Hietzing	NULL	Completed	18 Years	90 Years	All	12	N/A	Austria
2	EUCTR2017-004929-33-AT (EUCTR)	05/12/2018	27/11/2018	Effect of Ciclosporin eyedrops on symptoms of the eye and visual quality in patients with dry eye syndrome and primary or secondary Sjögren syndrome	Effect of Ciclosporin eyedrops on ocular symptoms and optical image quality in patients with primary or secondary Sjögren syndrome	primary or secondary Sjögren Syndrome;Therapeutic area: Diseases [C] - Eye Diseases [C11]	Trade Name: Ikervis Product Name: Ikervis INN or Proposed INN: CICLOSPORIN Trade Name: Softacort Product Name: Softacort INN or Proposed INN: HYDROCORTISONE SODIUM PHOSPHATE	KH Hietzing, Department of Ophthalmology	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	20	Phase 4	Austria
3	NCT02112019 (ClinicalTrials.gov)	June 2014	8/4/2014	Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome	Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome; A Randomised Controlled Pilot Study	Sjögren's Syndrome	Procedure: Sialoendoscopy;Drug: saline;Drug: hydrocortisone	Derk Jan Jager	NULL	Active, not recruiting	18 Years	70 Years	All	50	N/A	Netherlands